查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
醫用聚合物的全球市場：按類型、應用、製造技術和地區分類 – 預測（至 2029 年）
市場調查報告書
商品編碼
1479078

醫用聚合物的全球市場：按類型、應用、製造技術和地區分類 – 預測（至 2029 年）

Medical Polymer Market by type (Medical plastics, Medical elastomers), Application (Medical Disposables, Medical Instruments And Devices, Prosthetics, Diagnostics Instruments And Tools), Manufacturing Technology, and Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 427 Pages | 訂單完成後即時交付

價格
簡介目錄

全球醫用聚合物市場規模預計將從 2024 年的 4,110 萬美元增至 2029 年的 6,050 萬美元，預測期內複合年成長率為 8.0%。

由於人們對醫療保健品質和安全的日益關注，對醫用聚合物的需求不斷增加，從而促進了創新醫療器材與設備的發展。此外，聚合物技術的進步正在擴大醫用聚合物的功能和應用，促進其在各個醫療領域的採用。這種不斷成長的需求也推動了對醫療環境中生物相容、耐用且易於消毒的材料的需求。

調查範圍
調查年份 2020-2029
基準年 2023年
預測期 2024-2029
單元 金額（百萬美元）、數量（千噸）
部分 類型、用途、製造技術、地區
目標區域 亞太地區、北美、歐洲、中東/非洲、南美

“按以金額為準，醫用合成橡膠在細分市場中佔據第二大市場佔有率。”

醫用合成橡膠由於其獨特的性能和在醫療應用中的多功能性，在醫用聚合物領域佔據第二大市場佔有率。這些合成橡膠具有彈性、彈性和生物相容性等特性，非常適合用於需要彈性和耐用性的醫療設備和組件，例如導管、密封和手術手套。對醫用合成橡膠的需求也受到其承受滅菌過程和醫療環境中常見的惡劣化學環境的能力的推動。此外，合成橡膠配方和加工技術開發的進步導致性能提高和應用範圍擴大，有助於合成橡膠在醫用聚合物產業中佔據重要的市場影響。

“按以金額為準，一次性醫療用品在應用領域佔據第二大市場佔有率。”

由於多重因素的影響，一次性醫療用品在市場應用領域佔據第二大市場佔有率。首先，對感染控制和病人安全的日益擔憂正在推動對一次性醫療用品的需求，例如由醫用聚合物製成的注射器、手套和外科用覆蓋巾。這些一次性用品方便、無菌，並降低了交叉污染的風險，使其在醫療環境中至關重要。由於門診病人和居家醫療的增加，一次性醫療用品的消耗量也在增加。此外，聚合物技術的進步使得經濟高效且環保的一次性醫療產品的開發成為可能，進一步促進了它們的採用並為其巨大的市場佔有率做出了貢獻。

“按以金額為準，射出成型在市場製造技術領域佔據第二大佔有率。”

射出成型因其效率、精度和多功能性而在市場製造技術領域以金額為準第二大佔有率。該技術能夠大量生產複雜的客製化醫療零件，並具有一致的品質和尺寸精度。射出成型成型醫療設備和產品，例如注射器、靜脈注射導管和植入式器械，可以利用生物相容性、無菌性和耐用性等特性。此外，射出成型深受醫療設備製造商的歡迎，因為它可以實現經濟高效的生產、縮短前置作業時間並減少材料浪費。此外，射出成型技術的進步，包括自動化和數位化，進一步提高了醫用聚合物產業射出成型的能力和市場競爭力。

本報告研究和分析了全球醫用聚合物市場，提供了關鍵促進因素和限制因素、競爭格局和未來趨勢的資訊。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

  • 醫用聚合物市場對公司有吸引力的機會
  • 醫用聚合物市場：依類型
  • 醫用聚合物市場：依應用分類
  • 醫用聚合物市場：依製造技術分類
  • 醫用聚合物市場：依國家分類

第5章市場概況

  • 介紹
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
  • 波特五力分析
  • 總體經濟指標

第6章 產業趨勢

  • 介紹
  • 主要相關利益者和採購標準
  • 價值鏈分析
    • 原料
    • 製作者
    • 分配
    • 最終用戶
  • 生態系分析
  • 案例研究分析
  • 監管環境
  • 技術分析
    • 主要技術
    • 互補技術
    • 鄰近技術
  • 影響客戶業務的趨勢/干擾
  • 貿易分析
    • 導入場景
    • 出口場景
  • 重大會議及活動
  • 價格分析
    • 平均銷售價格趨勢：按地區
    • 平均銷售價格趨勢：依用途
    • 主要企業平均售價趨勢：依用途
  • 投資金籌措場景
  • 專利分析

第7章醫用聚合物市場：依類型

  • 介紹
  • 醫用塑膠
  • 醫用合成橡膠

第8章醫用聚合物市場：依製造技術分類

  • 介紹
  • 管材擠出
  • 壓縮成型
  • 射出成型
  • 其他製造技術

第9章醫用聚合物市場：依應用分類

  • 介紹
  • 醫療一次性用品
  • 醫療設備
  • 義肢
  • 診斷設備
  • 其他用途

第10章醫用聚合物市場：依地區

  • 介紹
  • 北美洲
    • 經濟衰退對北美的影響
    • 美國
    • 加拿大
    • 墨西哥
  • 亞太地區
    • 景氣衰退的影響
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 其他亞太地區
  • 歐洲
    • 景氣衰退的影響
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 中東/非洲
    • 景氣衰退的影響
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東/非洲
  • 南美洲
    • 景氣衰退的影響
    • 巴西
    • 阿根廷
    • 南美洲其他地區

第11章競爭格局

  • 概述
  • 主要企業策略
  • 市場佔有率分析
  • 收益分析
  • 公司評價及財務指標
  • 品牌/產品比較
  • 企業評價矩陣：主要企業（2023年）
  • 企業評價矩陣：Start-Ups、中小企業
  • 競爭格局及趨勢

第12章 公司簡介

  • 主要企業
    • BASF SE
    • SABIC
    • COVESTRO AG
    • CELANESE CORPORATION
    • EVONIK INDUSTRIES
    • ARKEMA
    • SOLVAY
    • KURARAY CO., LTD.
    • MOMENTIVE PERFORMANCE MATERIALS INC.
    • DUPONT
  • 其他公司
    • TRINSEO
    • KRATON CORPORATION
    • TOTAL PLASTICS
    • SIMONA AMERICA
    • DSM
    • INVIBIO
    • AVIENT CORPORATION
    • RTP COMPANY
    • TEKNIPLEX
    • TEKNOR APEX
    • MITSUBISHI CHEMICALS ADVANCED MATERIALS
    • WACKER CHIMIE
    • HARDIE POLYMERS
    • ELIX POLYMERS
    • INNOVATIVE POLYMER COMPOUNDS

第13章附錄

簡介目錄
Product Code: CH 9017

The global medical polymer market is expected to grow at a CAGR of 8.0% during the forecast period, from an estimated USD 41.1 million in 2024 to USD 60.5 million by 2029. The demand for medical polymers is increasing due to the growing emphasis on healthcare quality and safety, leading to the development of innovative medical devices and equipment. Additionally, advancements in polymer technology have expanded the capabilities and applications of medical polymers, driving their adoption across various medical fields. This rising demand is also fueled by the need for materials that offer biocompatibility, durability, and ease of sterilization in medical settings.

Scope of the Report
Years Considered for the Study2020-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million), Volume (Kiloton)
SegmentsType, Application, Manufacturing Technology, and Region
Regions coveredAsia Pacific, North America, Europe, Middle East & Africa, and South America

"Medical elastomers accounted for the second largest share in type segment of medical polymer market in terms of value."

Medical elastomers hold the second-largest market share in the medical polymer segment due to their unique properties and versatility in medical applications. These elastomers offer characteristics such as flexibility, resilience, and biocompatibility, making them ideal for use in medical devices and components that require elasticity and durability, such as catheters, seals, and surgical gloves. The demand for medical elastomers is also driven by their ability to withstand sterilization processes and harsh chemical environments commonly found in healthcare settings. Furthermore, ongoing developments in elastomer formulations and processing techniques continue to enhance their performance and expand their applications, contributing to their significant market presence in the medical polymer industry.

"Medical disposables accounted for the second largest share in application segment of medical polymer market in terms of value."

Medical disposables hold the second-largest market share in the application segment of the medical polymer market due to several key factors. Firstly, the increasing focus on infection control and patient safety has driven the demand for single-use medical products, such as syringes, gloves, and surgical drapes, made from medical polymers. These disposables offer convenience, sterility, and reduced risk of cross-contamination, making them essential in healthcare settings. Additionally, the rise in outpatient and home-based care has led to higher consumption of disposable medical supplies. Moreover, advancements in polymer technology have enabled the development of cost-effective and environmentally friendly disposable medical products, further fueling their adoption and contributing to their significant market share.

"Injection molding accounted for the second largest share in the manufacturing technology segment of medical polymer market in terms of value."

Injection molding holds the second-largest market share in the manufacturing technology segment of the medical polymer market due to its efficiency, precision, and versatility. This technology allows for the mass production of intricate and customized medical components with consistent quality and dimensional accuracy. Medical devices and products manufactured through injection molding, such as syringes, IV catheters, and implantable devices, benefit from properties like biocompatibility, sterilizability, and durability. Additionally, injection molding offers cost-effective production, shorter lead times, and reduced material wastage, making it highly favored by medical device manufacturers. Moreover, ongoing advancements in injection molding technology, including automation and digitalization, further enhance its capabilities and market competitiveness in the medical polymer industry.

"Europe is the second-largest market for medical polymer."

Europe holds the second-largest market share globally in the medical polymer market due to several key factors. Firstly, the region benefits from a well-established healthcare infrastructure, advanced research and development capabilities, and stringent regulatory standards, fostering innovation and quality in medical polymer products. Additionally, the increasing aging population and prevalence of chronic diseases drive the demand for advanced medical devices and equipment, which rely heavily on medical polymers. Moreover, Europe's strong emphasis on healthcare modernization, sustainability, and patient safety further propels the adoption of medical polymers. Furthermore, strategic collaborations between industry players, research institutions, and healthcare providers contribute to the region's leadership in the global medical polymer market.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the medical polymer market, and information was gathered from secondary research to determine and verify the market size of several segments.

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C Level Executives- 20%, Directors - 10%, and Others - 70%
  • By Region: North America - 20%, Europe - 20%, APAC - 40%, South America- 10% , and

the Middle East & Africa -10%

The medical polymer market comprises major players such as BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), DuPont (US), and others. The study includes in-depth competitive analysis of these key players in the medical polymer market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This report segments the market for medical polymer market on the basis of type, application, manufacturing technology, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products & services, key strategies, new product launches, expansions, and mergers & acquisition associated with the market for medical polymer market.

Key benefits of buying this report

This research report is focused on various levels of analysis - industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view on the competitive landscape; emerging and high-growth segments of the medical polymer market; high-growth regions; and market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the medical polymer market offered by top players in the global medical polymer market.
  • Analysis of drivers: (Increasing demand for biocompatible materials, Growing aging population globally, Advancements in medical technology, Regulatory support for medical-grade materials), restraints (Regulatory complexities and approvals, High competition from alternative materials, Environmental sustainability concerns), opportunities (Growth in regenerative medicine, Demand for minimally invasive devices, Advancements in biodegradable polymers), and challenges (Cost constraints for novel materials, Long term durability and degradation control) influencing the growth of medical polymer market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical polymer market.
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for medical polymer market across regions.
  • Market Capacity: Production capacities of companies producing medical polymer are provided wherever available with upcoming capacities for the medical polymer market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the medical polymer market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS AND EXCLUSIONS
    • TABLE 1 MEDICAL POLYMER MARKET: INCLUSIONS AND EXCLUSIONS
  • 1.4 STUDY SCOPE
    • FIGURE 1 MEDICAL POLYMER MARKET SEGMENTATION
    • 1.4.1 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 UNITS CONSIDERED
  • 1.7 STAKEHOLDERS
  • 1.8 IMPACT OF RECESSION

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 MEDICAL POLYMER MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of major secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary data sources: demand and supply sides
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 MARKET SIZE ESTIMATION APPROACH: DEMAND SIDE
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
    • FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 6 MEDICAL POLYMER MARKET: DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
    • 2.5.1 SUPPLY SIDE
    • 2.5.2 DEMAND SIDE
  • 2.6 RESEARCH LIMITATION
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

    • FIGURE 7 MEDICAL PLASTICS SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE DURING FORECAST PERIOD
    • FIGURE 8 MEDICAL INSTRUMENTS & DEVICES TO BE FASTEST-GROWING APPLICATION DURING FORECAST PERIOD
    • FIGURE 9 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL POLYMER MARKET
    • FIGURE 10 INCREASING DEMAND FROM MEDICAL INSTRUMENTS & DEVICES APPLICATION TO DRIVE MARKET DURING FORECAST PERIOD
  • 4.2 MEDICAL POLYMER MARKET, BY TYPE
    • FIGURE 11 MEDICAL PLASTICS SEGMENT TO LEAD MEDICAL POLYMER MARKET DURING FORECAST PERIOD
  • 4.3 MEDICAL POLYMER MARKET, BY APPLICATION
    • FIGURE 12 MEDICAL INSTRUMENTS & DEVICES SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.4 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY
    • FIGURE 13 EXTRUSION TUBING SEGMENT TO ACCOUNT FOR LARGEST SHARE OF MEDICAL POLYMER MARKET
  • 4.5 MEDICAL POLYMER MARKET, BY COUNTRY
    • FIGURE 14 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 15 MEDICAL POLYMER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for biocompatible materials
      • 5.2.1.2 Growing aging population globally
      • 5.2.1.3 Advancements in medical technology
      • 5.2.1.4 Regulatory support for medical-grade materials
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Regulatory complexities and approvals
      • 5.2.2.2 High competition from alternative materials
      • 5.2.2.3 Environmental sustainability concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth in regenerative medicine
      • 5.2.3.2 Demand for minimally invasive devices
      • 5.2.3.3 Advancements in biodegradable polymers
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Cost constraints for novel materials
      • 5.2.4.2 Long-term durability and degradation control
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 MEDICAL POLYMER MARKET: PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 16 PORTER'S FIVE FORCES ANALYSIS: MEDICAL POLYMER MARKET
    • 5.3.1 THREAT FROM NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF BUYERS
    • 5.3.4 BARGAINING POWER OF SUPPLIERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 MACROECONOMIC INDICATORS
    • 5.4.1 GLOBAL GDP TRENDS
    • TABLE 3 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2018-2025

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 KEY STAKEHOLDERS & BUYING CRITERIA
    • 6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS
    • TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS
    • 6.2.2 BUYING CRITERIA
    • FIGURE 18 KEY BUYING CRITERIA IN MAJOR APPLICATIONS
    • TABLE 5 KEY BUYING CRITERIA IN MAJOR APPLICATIONS
  • 6.3 VALUE CHAIN ANALYSIS
    • FIGURE 19 MEDICAL POLYMER MARKET: VALUE CHAIN ANALYSIS
    • 6.3.1 RAW MATERIAL
    • 6.3.2 MANUFACTURER
    • 6.3.3 DISTRIBUTION
    • 6.3.4 END USER
  • 6.4 ECOSYSTEM ANALYSIS
    • FIGURE 20 MEDICAL POLYMER MARKET: ECOSYSTEM MAPPING
    • TABLE 6 MEDICAL POLYMER MARKET: ROLE IN ECOSYSTEM
  • 6.5 CASE STUDY ANALYSIS
    • 6.5.1 EVONIK INDUSTRIES PROVIDES MEDICAL POLYMERS TO JENACELL GMBH FOR WOUND DRESSINGS, IMPLANTABLE MATERIALS, AND DRUG DELIVERY SYSTEMS
    • 6.5.2 ENSINGER OFFERS HIGH-PERFORMANCE, MEDICAL-GRADE POLYMERS FOR HIGH-FREQUENCY SURGERY
  • 6.6 REGULATORY LANDSCAPE
    • TABLE 7 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.7 TECHNOLOGY ANALYSIS
    • 6.7.1 KEY TECHNOLOGY
    • 6.7.2 COMPLEMENTARY TECHNOLOGY
    • 6.7.3 ADJACENT TECHNOLOGY
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
    • 6.8.1 REVENUE SHIFT AND NEW REVENUE POCKETS FOR MEDICAL POLYMER MANUFACTURERS
    • FIGURE 21 REVENUE SHIFT IN MEDICAL POLYMER MARKET
  • 6.9 TRADE ANALYSIS
    • 6.9.1 IMPORT SCENARIO
    • FIGURE 22 IMPORT OF MEDICAL POLYMERS, BY COUNTRY, 2019-2022 (USD THOUSAND)
    • 6.9.2 EXPORT SCENARIO
    • FIGURE 23 EXPORT OF MEDICAL POLYMERS, BY COUNTRY, 2019-2022 (USD THOUSAND)
  • 6.10 KEY CONFERENCES & EVENTS
    • TABLE 11 MEDICAL POLYMER MARKET: CONFERENCES & EVENTS, 2024-2025
  • 6.11 PRICING ANALYSIS
    • 6.11.1 AVERAGE SELLING PRICE TREND, BY REGION
    • FIGURE 24 AVERAGE SELLING PRICE TREND, BY REGION (USD/KILOTON)
    • 6.11.2 AVERAGE SELLING PRICE TREND, BY APPLICATION
    • FIGURE 25 AVERAGE SELLING PRICE TREND, BY APPLICATION (USD/KILOTON)
    • 6.11.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
    • FIGURE 26 AVERAGE SELLING PRICE, BY KEY MARKET PLAYERS (USD/ KILOTON)
  • 6.12 INVESTMENT AND FUNDING SCENARIO
    • FIGURE 27 INVESTMENT AND FUNDING SCENARIO, 2019-2023 (USD MILLION)
  • 6.13 PATENT ANALYSIS
    • 6.13.1 METHODOLOGY
    • 6.13.2 PATENTS GRANTED WORLDWIDE, 2013-2023
    • TABLE 12 TOTAL NUMBER OF PATENTS
    • 6.13.3 PATENT PUBLICATION TRENDS
    • FIGURE 28 TOTAL NUMBER OF PATENTS PUBLISHED FROM 2013 TO 2023
    • 6.13.4 INSIGHTS
    • 6.13.5 LEGAL STATUS OF PATENTS
    • FIGURE 29 PATENT ANALYSIS, BY LEGAL STATUS
    • 6.13.6 JURISDICTION-WISE PATENT ANALYSIS
    • FIGURE 30 TOP JURISDICTIONS FOR MEDICAL POLYMER PATENTS
    • 6.13.7 TOP COMPANIES/APPLICANTS
    • FIGURE 31 TOP 10 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENTS
    • 6.13.8 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS
    • TABLE 13 TOP TEN PATENT OWNERS

7 MEDICAL POLYMER MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • FIGURE 32 MEDICAL PLASTICS TO LEAD OVERALL MARKET DURING FORECAST PERIOD
    • TABLE 14 MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 15 MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 16 MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 17 MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
  • 7.2 MEDICAL PLASTICS
    • 7.2.1 ADVANCEMENTS IN MATERIAL SCIENCE AND MANUFACTURING TECHNOLOGIES TO DRIVE MARKET
    • 7.2.2 POLYPROPYLENE (PP)
    • 7.2.3 POLYVINYL CHLORIDE (PVC)
    • 7.2.4 POLYETHYLENE (PE)
    • 7.2.5 POLYSTYRENE (PS)
    • 7.2.6 ENGINEERING & HIGH-PERFORMANCE PLASTICS
      • 7.2.6.1 Polyether ether ketone (PEEK)
      • 7.2.6.2 Nylon/polyamide (PA)
      • 7.2.6.3 Polyphenulsulfone (PPSU)
      • 7.2.6.4 Polysulfones (PSU)
      • 7.2.6.5 Polymethyl methacrylate (PMMA)
      • 7.2.6.6 Polycarbonate (PC)
      • 7.2.6.7 Acrylonitrile butadiene styrene (ABS)
      • 7.2.6.8 Other engineering & high-performance plastics
    • 7.2.7 OTHER MEDICAL PLASTICS
  • 7.3 MEDICAL ELASTOMERS
    • 7.3.1 FLEXIBILITY, DURABILITY, AND BIOCOMPATIBILITY TO DRIVE MARKET
    • 7.3.2 SILICONE
    • 7.3.3 THERMOPLASTIC ELASTOMERS
      • 7.3.3.1 Thermoplastic polyurethane (TPU)
      • 7.3.3.2 Thermoplastic vulcanizates (TPV)
      • 7.3.3.3 Thermoplastic styrenic elastomers (TPS)
        • 7.3.3.3.1 Poly(styrene-butadiene-styrene) (SBS)
        • 7.3.3.3.2 Styrene-ethylene-butylene-styrene (SEBS)
      • 7.3.3.4 Thermoplastic copolyester elastomers (TPC-ET)
  • 7.4 OTHER MEDICAL ELASTOMERS

8 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY

  • 8.1 INTRODUCTION
    • FIGURE 33 EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
    • TABLE 18 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 19 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 20 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 21 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
  • 8.2 EXTRUSION TUBING
    • 8.2.1 INCREASING USE IN INTRAVENOUS DELIVERY SYSTEMS, CATHETERS, AND SURGICAL INSTRUMENTS TO DRIVE MARKET
  • 8.3 COMPRESSION MOLDING
    • 8.3.1 INCREASING USE IN PROSTHETICS, ORTHOPEDIC IMPLANTS, AND DENTAL COMPONENTS TO DRIVE MARKET
  • 8.4 INJECTION MOLDING
    • 8.4.1 INCREASING USE OF SYRINGES, SURGICAL INSTRUMENTS, AND IMPLANTABLE DEVICES TO DRIVE MARKET
  • 8.5 OTHER MANUFACTURING TECHNOLOGIES

9 MEDICAL POLYMER MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • FIGURE 34 MEDICAL INSTRUMENTS & DEVICES TO BE LARGEST APPLICATION OF MEDICAL POLYMER
    • TABLE 22 MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 23 MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 24 MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 25 MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • 9.2 MEDICAL DISPOSABLES
    • 9.2.1 INCREASING DEMAND FOR CATHETERS AND SYRINGES TO DRIVE MARKET
    • 9.2.2 GLOVES
    • 9.2.3 SYRINGES
    • 9.2.4 MEDICAL BAGS
    • 9.2.5 OTHER MEDICAL DISPOSABLES
  • 9.3 MEDICAL INSTRUMENTS & DEVICES
    • 9.3.1 INCREASING SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET
    • 9.3.2 MEDICAL TUBES
    • 9.3.3 CATHETERS
    • 9.3.4 DRUG DELIVERY
    • 9.3.5 OTHER MEDICAL INSTRUMENTS & DEVICES
  • 9.4 PROSTHETICS
    • 9.4.1 TECHNOLOGICAL DEVELOPMENTS TO DRIVE DEMAND
    • 9.4.2 IMPLANTS
    • 9.4.3 LIMB PROSTHESIS
    • 9.4.4 OTHER PROSTHETICS APPLICATIONS
  • 9.5 DIAGNOSTIC INSTRUMENTS & TOOLS
    • 9.5.1 INCREASING DEMAND IN SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET
    • 9.5.2 DENTAL TOOLS
    • 9.5.3 SURGICAL INSTRUMENTS
    • 9.5.4 OTHER DIAGNOSTIC INSTRUMENTS & TOOLS
  • 9.6 OTHER APPLICATIONS

10 MEDICAL POLYMER MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 35 MEDICAL POLYMER MARKET SNAPSHOT
    • TABLE 26 MEDICAL POLYMER MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 27 MEDICAL POLYMER MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 28 MEDICAL POLYMER MARKET, BY REGION, 2020-2023 (KILOTON)
    • TABLE 29 MEDICAL POLYMER MARKET, BY REGION, 2024-2029 (KILOTON)
  • 10.2 NORTH AMERICA
    • 10.2.1 IMPACT OF RECESSION ON NORTH AMERICA
    • FIGURE 36 NORTH AMERICA: MEDICAL POLYMER MARKET SNAPSHOT
    • TABLE 30 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 31 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 32 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (KILOTON)
    • TABLE 33 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (KILOTON)
    • TABLE 34 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 35 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 36 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 37 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 38 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 39 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 40 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 41 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • TABLE 42 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 43 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 44 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 45 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
    • 10.2.2 US
      • 10.2.2.1 High R&D investments in medical sector to drive market growth
    • TABLE 46 US: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 47 US: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 48 US: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 49 US: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 50 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 51 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 52 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 53 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.2.3 CANADA
      • 10.2.3.1 Emerging demand for dental implants to drive market
    • TABLE 54 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 55 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 56 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 57 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 58 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 59 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 60 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 61 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.2.4 MEXICO
      • 10.2.4.1 Rising focus of manufacturers to expand manufacturing facilities to drive market growth
    • TABLE 62 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 63 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 64 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 65 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 66 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 67 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 68 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 69 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • 10.3 ASIA PACIFIC
    • 10.3.1 RECESSION IMPACT
    • FIGURE 37 ASIA PACIFIC: MEDICAL POLYMER MARKET SNAPSHOT
    • TABLE 70 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 71 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 72 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (KILOTON)
    • TABLE 73 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (KILOTON)
    • TABLE 74 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 77 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 78 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 81 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • TABLE 82 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 85 ASIA PACIFIC, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
    • 10.3.2 CHINA
      • 10.3.2.1 Largest market for medical polymers in Asia Pacific
    • TABLE 86 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 87 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 88 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 89 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 90 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 91 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 92 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 93 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.3.3 INDIA
      • 10.3.3.1 Rapid economic growth and growing population to drive market growth
    • TABLE 94 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 95 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 96 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 97 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 98 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 99 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 100 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 101 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.3.4 SOUTH KOREA
      • 10.3.4.1 Advanced healthcare and medical technologies to propel market growth
    • TABLE 102 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 103 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 104 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 105 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 106 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 107 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 108 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 109 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.3.5 JAPAN
      • 10.3.5.1 Developments in minimally invasive treatment and robotic surgery to support market growth
    • TABLE 110 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 111 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 112 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 113 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 114 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 115 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 116 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 117 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.3.6 AUSTRALIA
      • 10.3.6.1 Regulatory compliance and strategic collaborations to support market growth
    • TABLE 118 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 119 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 120 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 121 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 122 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 123 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 124 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 125 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.3.7 REST OF ASIA PACIFIC
    • TABLE 126 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 127 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 128 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 129 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 130 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 131 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 132 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 133 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • 10.4 EUROPE
    • 10.4.1 RECESSION IMPACT
    • FIGURE 38 EUROPE: MEDICAL POLYMER MARKET SNAPSHOT
    • TABLE 134 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 135 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 136 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (KILOTON)
    • TABLE 137 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (KILOTON)
    • TABLE 138 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 139 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 140 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 141 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 142 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 143 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 144 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 145 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • TABLE 146 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 147 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 148 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 149 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
    • 10.4.2 GERMANY
      • 10.4.2.1 Rising demand in dental implant application to drive market
    • TABLE 150 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 151 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 152 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 153 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 154 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 155 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 156 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 157 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.4.3 FRANCE
      • 10.4.3.1 Aging population and sedentary lifestyle to drive demand
    • TABLE 158 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 159 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 160 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 161 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 162 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 163 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 164 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 165 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.4.4 UK
      • 10.4.4.1 Growing incidences of chronic diseases and government support for innovation to drive market
    • TABLE 166 UK: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 167 UK: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 168 UK: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 169 UK: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 170 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 171 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 172 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 173 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.4.5 ITALY
      • 10.4.5.1 Strong production facilities with presence of global players to propel market growth
    • TABLE 174 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 175 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 176 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 177 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 178 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 179 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 180 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 181 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.4.6 SPAIN
      • 10.4.6.1 Increase in government funding for healthcare sector to support market
    • TABLE 182 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 183 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 184 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 185 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 186 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 187 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 188 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 189 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.4.7 REST OF EUROPE
    • TABLE 190 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 191 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 192 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 193 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 194 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 195 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 196 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 197 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • 10.5 MIDDLE EAST & AFRICA
    • 10.5.1 RECESSION IMPACT
    • TABLE 198 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 199 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 200 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (KILOTON)
    • TABLE 201 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (KILOTON)
    • TABLE 202 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 203 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 204 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 205 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 206 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 207 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 208 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 209 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • TABLE 210 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 211 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 212 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 213 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
    • 10.5.2 SAUDI ARABIA
      • 10.5.2.1 Growing population and rise in aging population to drive market
    • TABLE 214 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 215 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 216 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 217 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 218 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 219 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 220 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 221 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.5.3 UAE
      • 10.5.3.1 Population growth and changing epidemiology expected to drive market growth
    • TABLE 222 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 223 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 224 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 225 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 226 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 227 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 228 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 229 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.5.4 SOUTH AFRICA
      • 10.5.4.1 NHI scheme, increased government spending on healthcare, and priority programs to propel market
    • TABLE 230 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 231 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 232 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 233 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 234 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 235 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 236 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 237 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.5.5 REST OF MIDDLE EAST & AFRICA
    • TABLE 238 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 239 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 240 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 241 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 242 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 243 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 244 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 245 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
  • 10.6 SOUTH AMERICA
    • 10.6.1 RECESSION IMPACT
    • TABLE 246 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 247 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 248 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020-2023 (KILOTON)
    • TABLE 249 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024-2029 (KILOTON)
    • TABLE 250 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 251 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 252 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 253 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 254 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 255 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 256 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 257 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • TABLE 258 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (USD MILLION)
    • TABLE 259 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (USD MILLION)
    • TABLE 260 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020-2023 (KILOTON)
    • TABLE 261 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024-2029 (KILOTON)
    • 10.6.2 BRAZIL
      • 10.6.2.1 Growing aging population, expanding economy, and increasing health awareness to drive market
    • TABLE 262 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 263 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 264 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 265 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 266 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 267 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 268 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 269 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.6.3 ARGENTINA
      • 10.6.3.1 Availability of highly trained specialists and low cost of medical services boosting medical tourism industry
    • TABLE 270 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 271 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 272 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 273 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 274 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 275 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 276 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 277 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)
    • 10.6.4 REST OF SOUTH AMERICA
    • TABLE 278 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (USD MILLION)
    • TABLE 279 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 280 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020-2023 (KILOTON)
    • TABLE 281 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024-2029 (KILOTON)
    • TABLE 282 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 283 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 284 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020-2023 (KILOTON)
    • TABLE 285 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024-2029 (KILOTON)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES
    • FIGURE 39 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL POLYMER MARKET BETWEEN 2021 AND 2024
  • 11.3 MARKET SHARE ANALYSIS
    • 11.3.1 RANKING OF KEY MARKET PLAYERS, 2023
    • FIGURE 40 RANKING OF TOP FIVE PLAYERS IN MEDICAL POLYMER MARKET, 2023
    • 11.3.2 MARKET SHARE ANALYSIS OF KEY PLAYERS
    • TABLE 286 MEDICAL POLYMER MARKET: DEGREE OF COMPETITION
    • FIGURE 41 MEDICAL POLYMER MARKET: SHARE OF KEY PLAYERS
      • 11.3.2.1 BASF SE
      • 11.3.2.2 SABIC
      • 11.3.2.3 Covestro AG
      • 11.3.2.4 Celanese Corporation
      • 11.3.2.5 Evonik Industries
  • 11.4 REVENUE ANALYSIS
    • FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2021-2024
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
    • FIGURE 43 COMPANY VALUATION OF LEADING COMPANIES IN MEDICAL POLYMER MARKET, 2023
    • FIGURE 44 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL POLYMER MARKET, 2023
  • 11.6 BRAND/PRODUCT COMPARISON
    • FIGURE 45 MEDICAL POLYMER MARKET: BRAND/PRODUCT COMPARISON
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • FIGURE 46 MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX, 2023
    • 11.7.5 COMPANY FOOTPRINT
      • 11.7.5.1 Company overall footprint
      • 11.7.5.2 Company type footprint
      • 11.7.5.3 Company application footprint
      • 11.7.5.4 Company region footprint
  • 11.8 COMPANY EVALUATION MATRIX: START-UPS AND SMES
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • FIGURE 47 MEDICAL POLYMER MARKET: START-UPS/SMES EVALUATION MATRIX, 2023
    • 11.8.5 COMPETITIVE BENCHMARKING
    • TABLE 287 MEDICAL POLYMER MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 288 MEDICAL POLYMER MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • 11.9 COMPETITIVE SCENARIO AND TRENDS
    • 11.9.1 PRODUCT LAUNCHES
    • TABLE 289 MEDICAL POLYMER MARKET: PRODUCT LAUNCHES, NOVEMBER 2021-MARCH 2024
    • 11.9.2 DEALS
    • TABLE 290 MEDICAL POLYMER MARKET: DEALS, JANUARY 2021-MARCH 2024
    • 11.9.3 EXPANSIONS
    • TABLE 291 MEDICAL POLYMER MARKET: EXPANSIONS, JANUARY 2021-MARCH 2024

12 COMPANY PROFILES

  • (Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Key strengths, Strategic choices, Weaknesses and competitive threats) **
  • 12.1 MAJOR PLAYERS
    • 12.1.1 BASF SE
    • TABLE 292 BASF SE: COMPANY OVERVIEW
    • FIGURE 48 BASF SE: COMPANY SNAPSHOT
    • TABLE 293 BASF SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 294 BASF SE: DEALS, JANUARY 2021-MARCH 2024
    • 12.1.2 SABIC
    • TABLE 295 SABIC: COMPANY OVERVIEW
    • FIGURE 49 SABIC: COMPANY SNAPSHOT
    • TABLE 296 SABIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 297 SABIC: DEALS, JANUARY 2021-MARCH 2024
    • 12.1.3 COVESTRO AG
    • TABLE 298 COVESTRO AG: COMPANY OVERVIEW
    • FIGURE 50 COVESTRO AG: COMPANY SNAPSHOT
    • TABLE 299 COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 300 COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2024
    • TABLE 301 COVESTRO AG: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.4 CELANESE CORPORATION
    • TABLE 302 CELANESE CORPORATION: COMPANY OVERVIEW
    • FIGURE 51 CELANESE CORPORATION: COMPANY SNAPSHOT
    • TABLE 303 CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 304 CELANESE CORPORATION: DEALS, JANUARY 2021-MARCH 2024
    • TABLE 305 CELANESE CORPORATION: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.5 EVONIK INDUSTRIES
    • TABLE 306 EVONIK INDUSTRIES: COMPANY OVERVIEW
    • FIGURE 52 EVONIK INDUSTRIES: COMPANY SNAPSHOT
    • TABLE 307 EVONIK INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 308 EVONIK INDUSTRIES: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2024
    • TABLE 309 EVONIK INDUSTRIES: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.6 ARKEMA
    • TABLE 310 ARKEMA: COMPANY OVERVIEW
    • FIGURE 53 ARKEMA: COMPANY SNAPSHOT
    • TABLE 311 ARKEMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 312 ARKEMA: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2024
    • TABLE 313 ARKEMA: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.7 SOLVAY
    • TABLE 314 SOLVAY: COMPANY OVERVIEW
    • FIGURE 54 SOLVAY: COMPANY SNAPSHOT
    • TABLE 315 SOLVAY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.8 KURARAY CO., LTD.
    • TABLE 316 KURARAY CO., LTD.: COMPANY OVERVIEW
    • FIGURE 55 KURARAY CO., LTD.: COMPANY SNAPSHOT
    • TABLE 317 KURARAY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 318 KURARAY CO., LTD.: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.9 MOMENTIVE PERFORMANCE MATERIALS INC.
    • TABLE 319 MOMENTIVE PERFORMANCE MATERIALS INC.: COMPANY OVERVIEW
    • TABLE 320 MOMENTIVE PERFORMANCE MATERIALS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 321 MOMENTIVE PERFORMANCE MATERIALS INC.: DEALS, JANUARY 2021-MARCH 2024
    • TABLE 322 MOMENTIVE PERFORMANCE MATERIALS INC.: EXPANSIONS, JANUARY 2021-MARCH 2024
    • 12.1.10 DUPONT
    • TABLE 323 DUPONT: COMPANY OVERVIEW
    • FIGURE 56 DUPONT: COMPANY SNAPSHOT
    • TABLE 324 DUPONT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 325 DUPONT: DEALS, JANUARY 2021-MARCH 2024
    • TABLE 326 DUPONT: EXPANSIONS, JANUARY 2021-MARCH 2024
  • *Details on Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Key strengths, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 TRINSEO
    • TABLE 327 TRINSEO: COMPANY OVERVIEW
    • 12.2.2 KRATON CORPORATION
    • TABLE 328 KRATON CORPORATION: COMPANY OVERVIEW
    • 12.2.3 TOTAL PLASTICS
    • TABLE 329 TOTAL PLASTICS: COMPANY OVERVIEW
    • 12.2.4 SIMONA AMERICA
    • TABLE 330 SIMONA AMERICA: COMPANY OVERVIEW
    • 12.2.5 DSM
    • TABLE 331 DSM: COMPANY OVERVIEW
    • 12.2.6 INVIBIO
    • TABLE 332 INVIBIO: COMPANY OVERVIEW
    • 12.2.7 AVIENT CORPORATION
    • TABLE 333 AVIENT CORPORATION: COMPANY OVERVIEW
    • 12.2.8 RTP COMPANY
    • TABLE 334 RTP COMPANY: COMPANY OVERVIEW
    • 12.2.9 TEKNIPLEX
    • TABLE 335 TEKNIPLEX: COMPANY OVERVIEW
    • 12.2.10 TEKNOR APEX
    • TABLE 336 TEKNOR APEX: COMPANY OVERVIEW
    • 12.2.11 MITSUBISHI CHEMICALS ADVANCED MATERIALS
    • TABLE 337 MITSUBISHI CHEMICALS ADVANCED MATERIALS: COMPANY OVERVIEW
    • 12.2.12 WACKER CHIMIE
    • TABLE 338 WACKER CHIMIE: COMPANY OVERVIEW
    • 12.2.13 HARDIE POLYMERS
    • TABLE 339 HARDIE POLYMERS: COMPANY OVERVIEW
    • 12.2.14 ELIX POLYMERS
    • TABLE 340 ELIX POLYMERS: COMPANY OVERVIEW
    • 12.2.15 INNOVATIVE POLYMER COMPOUNDS
    • TABLE 341 INNOVATIVE POLYMER COMPOUNDS: COMPANY OVERVIEW

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS